Leaderboards/Multiple Sclerosis Research Studies

Multiple Sclerosis Research Studies

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Simon Lovestone
Johnson & Johnson (United Kingdom)
99
2
C. Frank Bennett
Ionis Pharmaceuticals (United States)
81
3
Viktor von Wyl
ZHAW Zurich University of Applied Sciences
68
4
Eduardo Agüera
Instituto Maimónides de Investigación Biomédica de Córdoba
64
5
Jiawen Qi
Wannan Medical College
63
6
John A. Lincoln
The University of Texas Health Science Center at Houston
59
7
Valentina Fossati
New York Stem Cell Foundation
57
8
Doina Pîslă
Technical University of Cluj-Napoca
57
9
Yiping Jiang
Dongguan University of Technology
57
10
Mohammad Ali Salehinejad
TU Dortmund University
55

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Farhad Imam
BioVentures (United States)
99
2
Jeremy Chataway
National Institute for Health and Care Research
76
3
Megha Singh
University of Birmingham
64
4
Fedik Rahimov
AbbVie (United States)
60
5
Yu Gu
Kunming Medical University
55
6
Liuting Zeng
Chinese Academy of Medical Sciences & Peking Union Medical College
53
7
Michael Freeley
Dublin City University
53
8
Bilal Ahmed Khan
University of Swat
53
9
Anna Tsiakiri
Democritus University of Thrace
53
10
Yuping Yang
Manchester Academic Health Science Centre
52

Emerging Leaders Papers

1
A genome-wide CRISPR screen identifies the TNRC18 gene locus as a regulator of inflammatory signaling
Nature Communications|2025
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Geraldine Cambridge
University College London
99
2
Alan Horwich
Institute of Cancer Research
90
3
Hideyuki Okano
Keio University
89
4
Frances S Mair
University of Glasgow
86
5
Hans Lassmann
University of Vienna
83
6
Tomáš Kalinčík
The Royal Melbourne Hospital
78
7
Mary‐Claire King
University of Washington
74
8
Dana C. Crawford
Vanderbilt University
72
9
Richard A. Rudick
Biogen (United States)
72
10
Julien Cohen‐Adad
Polytechnique Montréal
72

All-Time Leaders Papers

1
Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
The Lancet Public Health|2018
1.2k cit.
2
Oligodendrocytes: biology and pathology
Acta Neuropathologica|2009
902 cit.
3
Multiple sclerosis: experimental models and reality
Acta Neuropathologica|2016
508 cit.
4
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
Molecular Brain|2012
389 cit.
5
iPS cell technologies: significance and applications to CNS regeneration and disease
Molecular Brain|2014
241 cit.
6
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
British Journal of Cancer|2005
230 cit.
7
Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts
Brain Pathology|2017
115 cit.
8
RNA-Binding Protein Musashi1 Modulates Glioma Cell Growth through the Post-Transcriptional Regulation of Notch and PI3 Kinase/Akt Signaling Pathways
PLoS ONE|2012
88 cit.
9
Sox10- Venus mice: a new tool for real-time labeling of neural crest lineage cells and oligodendrocytes
Molecular Brain|2010
88 cit.
10
Roles of STAT3/SOCS3 Pathway in Regulating the Visual Function and Ubiquitin-Proteasome-dependent Degradation of Rhodopsin during Retinal Inflammation
Journal of Biological Chemistry|2008
82 cit.

Indexing Multiple Sclerosis Research Studies Reagents

Citation data for reagents in this field is currently compiling.